MORTIMER IAN (PRESIDENT & CFO) sold 0.3% of their position (97.00 shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $4.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/3/2025ACC: 0001193125-25-307211
Officer· PRESIDENT & CFO
Since Sep 2019
-97.00
Net shares
Net seller
$4.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
97.00 disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−97.00
Price / share
$45.01
Trade value
$4.37K
% of position
0.3%
11/28/2025
31.30K→31.20K
Total
Net shares
−97.00
Net value
-$4.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 11/28/2025 | S · Sale | −97.00 | $45.01 | $4.37K | 0.3% | 31.30K | 31.20K |
| Total | −97.00 | -$4.37K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned14.30K
Total
14.30K indirect14.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 14.30K | Indirect |
| Total | 14.30K | 14.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported